Menu Back to Canadian-Pharmacovigilance-and-Risk-Management-Conference


DIA’s Canadian Pharmacovigilance and Risk Management Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.

Need approval in order to attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Travel Once, Learn Twice

Receive $150 off your registration fee when you register for this meeting and the co-located DIA Annual Canadian Meeting.

Check out our 2019 Program!


Want to learn more about Canadian Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Learn more

Who should attend?

Professionals involved in:
  • Clinical Safety/Pharmacovigilance
  • Clinical Research and Clinical Operations
  • Quality Assurance and Control
  • Regulatory Affairs and Operations
  • Policy
  • Compliance and Legal Affairs
    • Learning objectives

      At the end of this session participants should be able to:
      • Describe recent regulatory agency initiatives in Canada, Europe, and the US, to strengthen pharmacovigilance and risk management efforts within their respective regions
      • Discuss recent updates to the Canada Vigilance database and perspectives of Health Canada and industry on opportunities and challenges that these changes pose
      • Compare and contrast pharmacovigilance inspections by Health Canada, MHRA, and FDA, and discuss recent findings from Health Canada inspections
      • Discuss Health Canada and industry perspectives on current pharmacovigilance risk management requirements and best practices in Canada

      Program Committee

      • Rita  Cassola, RPh
        Rita Cassola, RPh Executive Director PV
        Certus PV Services Inc, Canada
      • Marcia  Bailey, BSN, MHS, RN
        Marcia Bailey, BSN, MHS, RN Safety Evaluation & Risk Management Scientific Director
        GSK, Canada
      • Colin  D'Cunha, MD, MHS, FRCPC
        Colin D'Cunha, MD, MHS, FRCPC Director, Global Medical Affairs
        Apotex Inc., Canada
      • Mélanie  Derry, PhD
        Mélanie Derry, PhD Associate Director
        Health Canada, Canada
      • Marc  Poitras, PhD, MBA
        Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
        Health Canada, Canada
      Load More

      Contact us

      Registration Questions?

      Send Email

      Check out our 2019 Program!

      On Demand Content Preview Webinar

      Cybersecurity and Implications for Pharmacovigilance

      Digital Learning Catalog

      DIA Learning: eLearning Soultions